Company Therapeutics Programs mAb THERAPEUTICS Research & Discovery Collaborations Investors
 
Pipeline Program


Recent news

Company Presentation Jan 2012|Jan 23, 2012
Compugen to Broaden and Accelerate Monoclonal Antibody Program for Oncology and Immunology|Dec 20, 2011
BioLineRx to Develop and Commercialize Novel Peptides|Dec 14, 2011
News on product candidates